Medical Cannabis for Migraine — Switzerland 2026
Migraine affects one in four women and one in twelve men in Switzerland. When triptans, beta-blockers and CGRP antibodies aren't enough, cannabis is a serious option — and much cheaper for members.
Cannabis reduces migraine frequency by 30–55 % and cluster attacks significantly. Preparations: THC-dominant flower (Bedrocan) for acute attacks, CBD-rich strains (Bediol) for prophylaxis. Prescription: neurologist or cannabis clinic. CannabisClub members pay 50 CHF flat instead of 190 CHF — sign up free.
What the studies show
Prospective study Cuttler 2020 (n=1,306): inhaled cannabis reduces migraine severity by an average of 47 %, effect stable over 6 months.
In chronic migraine (>15 days/month), cannabinoids reduced attack frequency by 40 % (Nicolodi 2017) — comparable to amitriptyline with fewer side effects.
Preparations & dosing
Acute: Bedrocan 22 % vaporised, 0.05–0.15 g at onset. Onset 5–10 min.
Prophylaxis: Bediol 6/8 or CBD oil 10 %, 25 mg twice daily in the evening.
Save as a CannabisClub member
External cannabis consultation: 180–220 CHF. CannabisClub members: 50 CHF flat including prescription and digital renewals. Over 4 prescriptions a year that's 500+ CHF saved.
Registration is free and takes 2 minutes. Become a member now and lock in prescription pricing.
FAQ
Does cannabis replace my triptans?
Rarely completely. Cannabis reduces frequency and severity; triptans often remain as rescue. Goal: fewer triptans, not zero.
How much does CannabisClub membership actually save?
External consult ~190 CHF, member 50 CHF flat. On quarterly renewals you save 560 CHF/year. Registration is free.
Does insurance cover cannabis for migraine?
Rarely — only in treatment-resistant chronic migraine after failure of at least 3 standard therapies. Art. 71a HIO coverage approval required.
Cannabis for Migraine — Prescription Switzerland 2026 (Members 50 CHF)